Cargando…

Targeting of the MYCN Protein with Small Molecule c-MYC Inhibitors

Members of the MYC family are the most frequently deregulated oncogenes in human cancer and are often correlated with aggressive disease and/or poorly differentiated tumors. Since patients with MYCN-amplified neuroblastoma have a poor prognosis, targeting MYCN using small molecule inhibitors could r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Müller, Inga, Larsson, Karin, Frenzel, Anna, Oliynyk, Ganna, Zirath, Hanna, Prochownik, Edward V., Westwood, Nicholas J., Henriksson, Marie Arsenian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032254/ https://www.ncbi.nlm.nih.gov/pubmed/24859015 http://dx.doi.org/10.1371/journal.pone.0097285

Ejemplares similares

Identification of Cytotoxic Drugs That Selectively Target Tumor Cells with MYC Overexpression
por: Frenzel, Anna, et al.
Publicado: (2011)

MYCN-enhanced Oxidative and Glycolytic Metabolism Reveals Vulnerabilities for Targeting Neuroblastoma
por: Oliynyk, Ganna, et al.
Publicado: (2019)

Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids
por: Wang, Huabo, et al.
Publicado: (2015)

The MYCN Protein in Health and Disease
por: Ruiz-Pérez, María Victoria, et al.
Publicado: (2017)

Target Genes of c-MYC and MYCN with Prognostic Power in Neuroblastoma Exhibit Different Expressions during Sympathoadrenal Development
por: Yuan, Ye, et al.
Publicado: (2023)

Destabilization of MYC/MYCN by the mitochondrial inhibitors, metaiodobenzylguanidine, metformin and phenformin
por: WANG, STEPHANIE S., et al.
Publicado: (2014)

MYCN mRNA degradation and cancer suppression by a selective small-molecule inhibitor in MYCN-amplified neuroblastoma
por: Liu, Tao, et al.
Publicado: (2022)

The Multiple Faces of MNT and Its Role as a MYC Modulator
por: Liaño-Pons, Judit, et al.
Publicado: (2021)

MYCN-amplified neuroblastoma maintains an aggressive and undifferentiated phenotype by deregulation of estrogen and NGF signaling
por: Dzieran, Johanna, et al.
Publicado: (2018)

OMIC-03. TRANSLATIONAL CONTROL IN MYC AND MYCN MEDULLOBLASTOMA
por: Schmidt, Christin, et al.
Publicado: (2021)

Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma cases
por: Mundo, Lucia, et al.
Publicado: (2019)

p53 controls genomic stability and temporal differentiation of human neural stem cells and affects neural organization in human brain organoids
por: Marin Navarro, Ana, et al.
Publicado: (2020)

Regulation of Normal and Neoplastic Proliferation and Metabolism by the Extended Myc Network
por: Prochownik, Edward V.
Publicado: (2022)

Metabolic rewiring in MYC-driven medulloblastoma by BET-bromodomain inhibition
por: Graziani, Vittoria, et al.
Publicado: (2023)

MYC proteins promote neuronal differentiation by controlling the mode of progenitor cell division
por: Zinin, Nikolay, et al.
Publicado: (2014)

Normal and Neoplastic Growth Suppression by the Extended Myc Network
por: Prochownik, Edward V., et al.
Publicado: (2022)

Lessons in aging from Myc knockout mouse models
por: Prochownik, Edward V., et al.
Publicado: (2023)

MEDB-36. Clinical and molecular heterogeneity withinMYC andMYCN amplified medulloblastoma
por: Schwalbe, Edward, et al.
Publicado: (2022)

Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5
por: Wang, Huabo, et al.
Publicado: (2013)

Erratum: Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5
por: Wang, Huabo, et al.
Publicado: (2018)

PROTAC Bromodomain Inhibitor ARV-825 Displays Anti-Tumor Activity in Neuroblastoma by Repressing Expression of MYCN or c-Myc
por: Li, Zhiheng, et al.
Publicado: (2020)

Structurally diverse c-Myc inhibitors share a common mechanism of action involving ATP depletion
por: Wang, Huabo, et al.
Publicado: (2015)

Myc/Mycn-mediated glycolysis enhances mouse spermatogonial stem cell self-renewal
por: Kanatsu-Shinohara, Mito, et al.
Publicado: (2016)

ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors
por: Mainwaring, Oliver J., et al.
Publicado: (2023)

Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study
por: Wang, L L, et al.
Publicado: (2015)

Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation
por: Le Grand, Marion, et al.
Publicado: (2020)

The Role for Myc in Coordinating Glycolysis, Oxidative Phosphorylation, Glutaminolysis, and Fatty Acid Metabolism in Normal and Neoplastic Tissues
por: Goetzman, Eric S., et al.
Publicado: (2018)

Small molecules remain on target for c-Myc
por: Sun, Linchong, et al.
Publicado: (2017)

Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
por: Westermann, Frank, et al.
Publicado: (2008)

EMBR-07. MYC BUT NOT MYCN GENERATES AGGRESSIVE GROUP 3 MEDULLOBLASTOMA BY ARF PATHWAY SUPPRESSION
por: Mainwaring, Oliver, et al.
Publicado: (2021)

MycPermCheck: the Mycobacterium tuberculosis permeability prediction tool for small molecules
por: Merget, Benjamin, et al.
Publicado: (2013)

MycN Is Critical for the Maintenance of Human Embryonic Stem Cell-Derived Neural Crest Stem Cells
por: Zhang, Jie Ting, et al.
Publicado: (2016)

MYCN and MAX alterations in Wilms tumor and identification of novel N-MYC interaction partners as biomarker candidates
por: Jiménez Martín, Ovidio, et al.
Publicado: (2021)

Tumor cell-specific inhibition of MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase
por: Peter, Stefanie, et al.
Publicado: (2014)

Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression
por: Felsenstein, Kenneth M., et al.
Publicado: (2015)

MYCN and the epigenome
por: He, Stanley, et al.
Publicado: (2013)

Reversible Linkage of Two Distinct Small Molecule Inhibitors of Myc Generates a Dimeric Inhibitor with Improved Potency That Is Active in Myc Over-Expressing Cancer Cell Lines
por: Wanner, Jutta, et al.
Publicado: (2015)

miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
por: Ma, Li, et al.
Publicado: (2010)

Correction: MycN Is Critical for the Maintenance of Human Embryonic Stem Cell-Derived Neural Crest Stem Cells
por: Zhang, Jie Ting, et al.
Publicado: (2016)

MycN promotes TRPM7 expression and cell migration in neuroblastoma through a process that involves polyamines
por: Lange, Ingo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l81nkb6nivfjdmbbpatf1dsgsh